Oxidative stress plays a big role in the brain cell loss that occurs in Parkinson’s disease. Now scientists have their sights on a protein that inhibits one of the body’s natural protections against it. The blocker is Bach1, a protein and...
The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson’s disease, researchers say. The oral drug, dimethylfumarate, or DMF, and its metabolite, monomethylfumarate, or MMF...